Group refines its charge and begins to identify issues to be addressed and barriers to be overcome to enable the development and clinical application of molecular diagnostics for cancer. Support for the development of technology for the molecular characterization of cells is identified as a high priority. Several innovative new technologies that may be useful in both discovery and diagnostics are described.
Participants outline the next series of actions to be taken.
These include an emphasis on gene discovery, mapping of ESTs, and enhancing access to existing technologies.